Andrés Mazariegos Herrera
PhD student at Department of Pharmacy; Pharmacometrics; Tropical Pharmacology and Therapeutics
- E-mail:
- andres.mazariegos-herrera@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA
Short presentation
My reseach is precision dosing for Leishmaniasis, getting the right dose to the right patient considering their age, demographics and comorbidities. I work with Miltefosine, the only oral drug approved for the treatment of leishmaniasis, and a great deal of my reseach focuses in pediatrics. Through my reseach I aspire to impact dosing guidelines and provide caretakers in the areas where this disease is present with the right tools to decrease the burden.
Keywords
- Precision medicine
- Leishmaniasis
- Pediatrics
- Weight-banded dosing
- Population pharmacokinetics
- Pharmacometrics
- Modelling and Simulation
- Population statistics
- Miltefosine
- Global health

Publications
Recent publications
-
Part of Journal of Antimicrobial Chemotherapy, 2026
- DOI for Weight-band-based simplification of oral allometric miltefosine dosing in paediatric patients with visceral leishmaniasis
- Download full text (pdf) of Weight-band-based simplification of oral allometric miltefosine dosing in paediatric patients with visceral leishmaniasis
All publications
Articles in journal
-
Part of Journal of Antimicrobial Chemotherapy, 2026
- DOI for Weight-band-based simplification of oral allometric miltefosine dosing in paediatric patients with visceral leishmaniasis
- Download full text (pdf) of Weight-band-based simplification of oral allometric miltefosine dosing in paediatric patients with visceral leishmaniasis